Reuters logo
3 months ago
BRIEF-Onxeo gets 10th positive DSMB recommendation to continue Livatag relive phase III trial in HCC
May 23, 2017 / 4:06 PM / 3 months ago

BRIEF-Onxeo gets 10th positive DSMB recommendation to continue Livatag relive phase III trial in HCC

May 23 (Reuters) - ONXEO SA

* ONXEO ANNOUNCES 10TH POSITIVE DSMB RECOMMENDATION TO CONTINUE LIVATAG® RELIVE PHASE III TRIAL IN HCC Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below